tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PMN Stock Latest News

ProMIS Neurosciences announces publication highlighting PMN310
The FlyProMIS Neurosciences announces publication highlighting PMN310
5d ago
PMN
ProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Candidate
PremiumRatings
ProMIS Neurosciences: Buy Rating Backed by Innovative EpiSelect™ Platform and Promising PMN310 Candidate
7d ago
PMN
ProMIS Neurosciences: Buy Rating Affirmed Amid Promising PMN310 Progress and Favorable Valuation
PremiumRatings
ProMIS Neurosciences: Buy Rating Affirmed Amid Promising PMN310 Progress and Favorable Valuation
14d ago
PMN
ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
PremiumThe Fly
ProMIS Neurosciences target adjusted to $18 from $4 at H.C. Wainwright
14d ago
PMN
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
PremiumThe Fly
ProMIS Neurosciences announces publication on plasma pTau in Alzheimer’s
14d ago
PMN
Promis Neurosciences Inc trading halted, news pending
PremiumThe FlyPromis Neurosciences Inc trading halted, news pending
18d ago
PMN
ProMIS Neurosciences Announces Reverse Stock Split
Premium
Company Announcements
ProMIS Neurosciences Announces Reverse Stock Split
21d ago
8K
PMN
ProMIS Neurosciences announces 1-for-20 reverse stock split
Premium
The Fly
ProMIS Neurosciences announces 1-for-20 reverse stock split
21d ago
PMN
ProMIS Neurosciences Approves Key Shareholder Proposals
PremiumCompany Announcements
ProMIS Neurosciences Approves Key Shareholder Proposals
26d ago
8K
PMN
ProMIS Neurosciences price target lowered to $5 from $6 at Guggenheim
PremiumThe Fly
ProMIS Neurosciences price target lowered to $5 from $6 at Guggenheim
27d ago
PMN
Promising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
PremiumRatings
Promising Advancements in Alzheimer’s Research and Strong Financial Position Support Buy Rating for ProMIS Neurosciences
1M ago
PMN
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss
PremiumCompany Announcements
ProMIS Neurosciences Reports Increased R&D Costs and Net Loss
1M ago
PMN
ProMIS Neurosciences reports Q3 EPS (24c) vs 31c last year
PremiumThe FlyProMIS Neurosciences reports Q3 EPS (24c) vs 31c last year
1M ago
PMN
PMN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PMN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
PMN
ProMIS Neurosciences Advances Alzheimer’s Study with PMN310
Premium
Company Announcements
ProMIS Neurosciences Advances Alzheimer’s Study with PMN310
2M ago
PMN
ProMIS Neurosciences Appoints New Board Member
PremiumCompany Announcements
ProMIS Neurosciences Appoints New Board Member
2M ago
8K
PMN
ProMIS Neurosciences Amends Employment Agreement with CSO
PremiumCompany Announcements
ProMIS Neurosciences Amends Employment Agreement with CSO
3M ago
8K
PMN
ProMIS Neurosciences files to sell 28.23M common shares for holders
PremiumThe Fly
ProMIS Neurosciences files to sell 28.23M common shares for holders
3M ago
PMN
Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target
PremiumRatings
Promising Outlook for ProMIS Neurosciences’ PMN310 in Alzheimer’s Treatment with Buy Rating and $3.00 Price Target
3M ago
PMN
ProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase
PremiumCompany AnnouncementsProMIS Neurosciences Advances Alzheimer’s Trial to Final Phase
3M ago
8K
PMN
ProMIS receives DSMB approval to advance final dose escalation cohort
Premium
The Fly
ProMIS receives DSMB approval to advance final dose escalation cohort
3M ago
PMN
ProMIS Neurosciences Announces At The Market Offering
Premium
Company Announcements
ProMIS Neurosciences Announces At The Market Offering
4M ago
8K
PMN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >